Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy

Asian Pacific Journal of Allergy and Immunology

Volumn 28, Issue 1, 2010, Pages 7-13

  Harmanci, Koray ^a   Razi, Cem H ^a   Toyran, Muge ^a   Kanmaz, Gozde ^a   Cengizlier, Mehmet R ^b  

^a MINISTRY OF HEALTH   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HOUSE DUST ALLERGEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; POLLEN ANTIGEN; STEROID;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ALTERNARIA; ARTICLE; CHILD; CLINICAL TRIAL; COCKROACH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DANDER; DERMATOPHAGOIDES; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MILD INTERMITTENT ASTHMA; MOLECULAR MECHANICS; SCHOOL CHILD; SENSITIZATION; SPECIFIC IMMUNOTHERAPY; TREATMENT DURATION;

ADOLESCENT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CELL EXTRACTS; CHILD; DESENSITIZATION, IMMUNOLOGIC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PYROGLYPHIDAE; RESPIRATORY FUNCTION TESTS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS; TREATMENT OUTCOME;

EID: 77954556010     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Noon L, Cantab BC, Eng FRCS. Prophylactic inoculation against hay fever. Lancet 1911; 177: 1572-3.
2. Freeman J. Prophylactic vaccination against hay fever: Lancet 1916; 187: 532.
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO workshop report. National Institute of Health. National Heart, Lung and Blood Institute. 2002; 02-3659 Revised.
4. WHO Position Paper. Allergen immunotherapy. Therapeutic vaccines for allergic diseases. Allergy 1998; 53: S1-42.
5. Ownby DR, Adinoff AD. The appropriate use of skin testing and allergen immunotherapy in young children. J Allergy Clin Immunol 1994; 94: 662-5.
6. Walker SM, Varney VA, Gaga M, et al. Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy 1995; 50: 405-13.
7. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2000; CD001186.
8. Calderon MA, Carr VA, Jacobson M, Sheikh A, Durham S. Allergen injection immunotherapy for perennial allergic rhinitis. Cochrane Database of Syst Rev 2008; CD007163. DOI: 10.1002/14651858.
9. Des Roches A, Paradis LM, Menardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450-3.
10. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children mono-sensitized to house dust mite by specific immunotherapy. A six year follow-up study. Clin Exp Allergy 2001; 31: 1392-7.
11. Purello-D'Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in mono-sensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001; 31: 1295-302.
12. Inal A, Altintas DU, Yilmaz M, Karakoc GB, Kendirli SG, Sertdemir Y. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol 2007; 17: 85-91.
13. Asero R. Injection immunotherapy with different airborne allergens did not prevent de novo sensitization to ragweed and birch pollen north of Milan. Int Arch Allergy Immunol 2004; 133: 49-54.
14. Asero R. Pollen specific immunotherapy is not a risk factor for de novo sensitization to cross-reacting allergens in monosensitized subjects. J Investig Allergol Clin Immunol 2006; 16: 253-7.
15. Gulen F, Zeyrek D, Can D, et al. Development of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. Asian Pac J Allergy Immunol 2007; 25: 7-11.
16. Dreborg S, Frew A. Allergen standardization and skin tests. EAACI position paper. Allergy 1993; 48: S49-82.
17. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseason grass pollen immunotherapy in childhood. Allergy 2006; 61: 198-201.
18. Pifferi M, Baldini G, Marrazzini G, et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospec-tive study. Allergy 2002; 57: 785-90.
19. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102: 157-64.
20. Akoum H, Tsicopoulos A, Vorgn H, et al. Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes. Immunology 1996; 87: 593-8.
21. Durham SR, Ying S, Varney VA. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing m-RNA for interferon-gamma. J Allergy Clin Immunol 1996; 97: 1356-65.
22. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in a decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154: 4187-94.
23. Secrist H, Chelen CJ, Wen Y. Allergen immunotherapy decreases interleukin-4 production in CD4+ T cells from allergic individuals. J Exp Med 1993; 178: 2123-30.
24. Lack G, Nelson HS, Amran D, et al. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells. J Allergy Clin Immunol 1997; 99: 530-8.
25. Barbee RA, Kaltenborn W, Lebowitz MD, Burrows B. Longitudinal changes in allergen skin test reactivity in a community population sample. J Allergy Clin Immunol 1987; 79: 16-24.
26. Silvestri M, Oddera S, Rossi GA, Crimi P. Sensitization to airborne allergens in children with respiratory symptoms. Ann Allergy Asthma Immunol 1996; 76: 239-44.
27. Silvestri M, Rossi GA, Cozzani S, Pulvirenti G, Fasce L. Age dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann Allergy Asthma Immunol 1999; 83: 335-40.
28. Pi{dotless}nar NM, Saki{dotless}yan N, Inceoglu O, Kaplan A. A one-year aeropalynological study at Ankara, Turkey. Aerobiologia 1999; 15: 307-10.
29. Sin BC, Elik G, Pi{dotless}nar NM, Mungan D, Mi{dotless}si{dotless}rli{dotless}gil Z. Is pre-seasonal immunotherapy effective in patients with respiratory allergy? EAACI 2003; 57: 53.
30. Charpin D, Sibbald B, Weeke E, Wuthrich B. Epidemiological identification of allergic rhinitis. Allergy 1996; 51: 293-8.
31. Broder I, Higgins M, Matthews K, Keller J. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Mich. III. Second survey of the community. J Allergy Clin Immunol 1974; 53: 127-38.
32. Kjellmann B, Dahlen G. Long-term changes in inhalant allergy in asthmatic children. Allergy 1986; 41: 351-6.